<p class="CxSpFirst" style="margin-bottom: 32px; margin-left: 96px;"><span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">08:30 . Welkom<br /> 08:55 . Introductie&nbsp;| Olivier Vandenberg, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span style="box-sizing:border-box"><span style="color:#113671">Sessie 1: Oncologie en laboratoriumgeneeskunde</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span style="box-sizing:border-box"><span style="color:#113671">Chairman:&nbsp; Frédéric Cotton, LHUB-ULB</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">09:00· WHO perspective on the contribution of academic clinical laboratories in cancer research<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Prof. Zisis Kozlakidis, MD, PhD, Head, Laboratory Services and Biobanking at International<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;Agency for Research on Cancer (IARC), WHO, Lyon, France</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">09:45. The Role of Laboratory Medicine in Precision oncology: future or illusion?<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Marc Van Den Bulcke, Head Cancer Centre, Sciensano, Brussels, Belgium</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">10:15&nbsp;<b style="box-sizing:border-box; font-weight:700">.</b>&nbsp;Weefsel- en circulerende biomarkers in de oncologie: vooruitgang, beperkingen<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;en hoop van de clinicus<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Yassine Lalami, Kliniek voor medische oncologie, Jules Bordet Instituut</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><i style="box-sizing:border-box">Coffee break (10:45-11:15)</i></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">11:15 . Paraeoplastische syndromen<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Julie Smets, Dienst Immunologie, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">11:45&nbsp;<b style="box-sizing:border-box; font-weight:700">. </b>Flowcytometrie en verdachte proliferatie in de hematologie<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Valéry Daubie &amp; Hussein Farhat, Dienst Hematologie, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><i style="box-sizing:border-box">Lunch break &amp; Sponsors exhibition (12:15-13:30)</i></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#113671">Sessie 2: Unieke kenmerken van het universitaire laboratorium</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#113671">Chairman:&nbsp;&nbsp;</span></span></b><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#002060">Olivier Vandenberg, LHUB-ULB</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">13:30 . Bijdrage van de cluster Optilab Montréal CHUM aan de activiteiten van de Universiteit<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;van Montréal<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Christian Lavallée, MD, MSc, FRCPC, Medisch Directeur, OPTILAB Montréal CHUM Cluster,<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Universiteit van Montréal</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">14:15&nbsp;<b style="box-sizing:border-box; font-weight:700">.&nbsp;</b>Bijdrage van LHUB-ULB aan de fundamentele missies van de universiteit.&nbsp; Stand van zaken<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;en verwachtingen van de&nbsp;Pôle Santé van de Université libre de Bruxelles<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Olivier Vandenberg, Eenheid Onderzoek en Technologische Innovatie (EOTI), LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font face="Calibri, sans-serif"><font style="box-sizing:border-box"><span style="font-size:14.6667px"><span style="box-sizing:border-box">14:45 . LHUB-ULB in het hart van een Europees netwerk voor zeldzame hematologische ziekten:<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;stoppen of doorgaan?<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Béatrice Gulbis, LHUB-ULB</span></span></font></font></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt; text-indent:-69.75pt"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">15:30 . Conclusies&nbsp;| Anne Demulder, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></p> , Symposium - LHUB-ULB annual, Symposium - LHUB-ULB annual
<p>Naast de routineactiviteiten draagt de LHUB-ULB ook bij aan de ontwikkeling van innovatieve benaderingen voor een betere diagnose, preventie en behandeling van ziekten die in de verschillende aangesloten ziekenhuizen worden aangetroffen. In dit licht werd begin 2018 een transversale dienst voor technologische innovatie (UNIT - Unité d’Innovation Technologique) opgericht, die de samenwerking met de academische wereld, private structuren en bedrijven moet versterken.</p> <p>De afdeling is georganiseerd in 3 operationele sectoren die samenwerken met de medische diensten en de ondersteunende sectoren van LHUB-ULB</p> , Technologische innovatie, Technologische innovatie
UMC Sint-Pieter - Cesar de Paepe, UMC Sint-Pieter - Cesar de Paepe
UMC Sint-Pieter - Hallepoort, UMC Sint-Pieter - Hallepoort
Universitair Kinderziekenhuis Koningin Fabiola, Universitair Kinderziekenhuis Koningin Fabiola
<p>Het is nu een van de vijf grootste universitaire ziekenhuislaboratoria in Europa geworden.</p> <p>De krijtlijnen voor dit project dateren uit de jaren 90, maar het is pas in 2008 dat de iris-Koepel het principieel besluit neemt om een laboratorium voor klinische biologie op te richten, gemeenschappelijk voor het hele net. De bedoeling is uiteraard om de doelmatigheid van analyses en dus de kwaliteit ervan te verbeteren.</p> <p><a class="btn" href="/nl/ontstaansgeschiedenis" title="Meer info">Meer info</a></p> , Universitair Laboratorium Brussel, Universitair Laboratorium Brussel
UVC Brugmann Brien, UVC Brugmann Brien
UVC Brugmann Horta, UVC Brugmann Horta
Werken bij de ULB, Werken bij de ULB
<p>9&nbsp;</p> , Ziekenhuiscampussen, Ziekenhuiscampussen